Printer Friendly

THERAPEUTIC DISCOVERY APPOINTS NEW BOARD MEMBER

 PALO ALTO, Calif., Aug. 24 /PRNewswire/ -- Therapeutic Discovery Corp. (TDC)(NASDAQ: TDCAZ) today announced the appointment of William P. Sommers, Ph.D. to its board of directors.
 Sommers, 60, is currently executive vice president of Iameter Inc., a medical information and education company which provides services to improve the quality and efficiency of health care delivery. He also serves as a member of the board of trustees of Kemper Mutual Funds, as a director of Rohr Inc. and as a member of the National Advisory Council, University of Michigan, College of Engineering. Prior to joining Iameter in 1992, Sommers spent 30 years at Booz, Allen & Hamilton in various positions including president of the Technology Management Group and manager of Asia/Pacific/Japan operations. He also served at Martin Marietta Co. and the Institute of Science and Technology at the University of Michigan. Sommers has been a member of the board of directors at Cetus Corp. and a member of the Scientific Advisory Board of Hoechst-Celanese. He has served on the International Council on Innovation and Technology, the Engineering Advisory Council at the University of California at Davis and as a trustee of the Criminal Justice Legal Foundation.
 Sommers joins Terrence Blaschke, M.D., Paul Lairson, M.D., Allen Phipps and Gary Neil, Ph.D. on the TDC board of directors. Blaschke is professor of medicine and pharmacology and chief of the Division of Clinical Pharmacology at the Stanford University School of Medicine. Lairson is a private consultant working with medical groups, large employers and hospitals on issues related to managed care, and currently serves on a Kaiser Permanente Medical Care Program task force on health care reform. Phipps, who is currently managing director of Business Engineering Inc., a business development and consulting firm, serves as chairman of the board. Neil, president and chief executive officer of TDC, was previously with American Home Products Corp. as executive vice president of American Home Products' subsidiary Wyeth-Ayerst Research, where he had been responsible for Wyeth-Ayerst's worldwide research and development organization.
 TDC was formed by ALZA Corp. (NYSE: AZA), a Palo Alto-based drug delivery company, to develop new human pharmaceutical products combining ALZA's proprietary drug delivery systems with various drug compounds and commercializing such products, most likely through licensing to ALZA. ALZA's option to license any products developed by TDC, provides ALZA with a potential pipeline of products for worldwide commercialization. ALZA also has an option to purchase all of the outstanding shares of TDC common stock.
 -0- 8/24/93
 /CONTACT: Kera Alexander of Therapeutic Discovery, 415-496-8200/
 (TDCAZ AZA)


CO: Therapeutic Discovery Corp.; ALZA Corp. ST: California IN: MTC SU: PER

SG-CK -- SJ002 -- 5442 08/24/93 12:20 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Aug 24, 1993
Words:447
Previous Article:CML GROUP AND THE NATURE CO. ANNOUNCE NEW PRESIDENT FOR THE NATURE CO.
Next Article:AUTO AFFORDABILITY AT BEST LEVEL IN 5+ YEARS
Topics:

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters